NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), a medical technology company specializing in neurological disorder surgical care solutions, has announced its participation in the upcoming MedInvest MedTech, AI and Digital Health Conference. The event will take place on June 3-4, 2025, at the O'Melveny Conference Center in San Francisco, CA.
Dave Rosa, President and CEO of NeuroOne, will be conducting investor meetings during this two-day conference, which will feature panel discussions, keynote talks, and corporate presentations focusing on medical devices, imaging technologies, diagnostics, AI/data analytics, and digital health. The MedInvest Conference is recognized as a leading conference series in Healthcare and Life Sciences, hosting semiannual events in Biotech, Pharma, MedTech, AI, and Digital Health sectors.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), un'azienda tecnologica medica specializzata in soluzioni chirurgiche per disturbi neurologici, ha annunciato la sua partecipazione alla prossima Conferenza MedInvest MedTech, AI e Salute Digitale. L'evento si terrà il 3 e 4 giugno 2025 presso l'O'Melveny Conference Center di San Francisco, CA.
Dave Rosa, Presidente e CEO di NeuroOne, terrà incontri con investitori durante questa conferenza di due giorni, che includerà tavole rotonde, discorsi principali e presentazioni aziendali focalizzate su dispositivi medici, tecnologie di imaging, diagnostica, intelligenza artificiale/analisi dati e salute digitale. La Conferenza MedInvest è riconosciuta come una delle principali serie di eventi nei settori Healthcare e Scienze della Vita, organizzando eventi semestrali nei campi di Biotech, Pharma, MedTech, AI e Salute Digitale.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), una empresa de tecnología médica especializada en soluciones quirúrgicas para trastornos neurológicos, ha anunciado su participación en la próxima Conferencia MedInvest MedTech, IA y Salud Digital. El evento se llevará a cabo los 3 y 4 de junio de 2025 en el O'Melveny Conference Center en San Francisco, CA.
Dave Rosa, presidente y CEO de NeuroOne, realizará reuniones con inversores durante esta conferencia de dos días, que contará con paneles de discusión, ponencias principales y presentaciones corporativas centradas en dispositivos médicos, tecnologías de imagen, diagnóstico, inteligencia artificial/análisis de datos y salud digital. La Conferencia MedInvest es reconocida como una de las principales series de conferencias en Salud y Ciencias de la Vida, organizando eventos semestrales en Biotecnología, Farmacéutica, MedTech, IA y Salud Digital.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)는 신경 질환 수술 치료 솔루션을 전문으로 하는 의료 기술 회사로, 다가오는 MedInvest MedTech, AI 및 디지털 헬스 컨퍼런스에 참가한다고 발표했습니다. 행사는 2025년 6월 3일부터 4일까지 캘리포니아 샌프란시스코의 O'Melveny 컨퍼런스 센터에서 열립니다.
NeuroOne의 사장 겸 CEO인 Dave Rosa는 이틀간 진행되는 이번 컨퍼런스에서 투자자 미팅을 진행할 예정이며, 이 행사는 의료기기, 영상 기술, 진단, AI/데이터 분석, 디지털 헬스에 중점을 둔 패널 토론, 기조 강연 및 기업 발표를 포함합니다. MedInvest 컨퍼런스는 헬스케어 및 생명과학 분야에서 선도적인 컨퍼런스 시리즈로 인정받고 있으며, 생명공학, 제약, MedTech, AI 및 디지털 헬스 분야에서 반기별 행사를 개최합니다.
NeuroOne Medical Technologies Corporation (NASDAQ : NMTC), une entreprise de technologie médicale spécialisée dans les solutions chirurgicales pour les troubles neurologiques, a annoncé sa participation à la prochaine Conférence MedInvest MedTech, IA et Santé Numérique. L'événement se tiendra les 3 et 4 juin 2025 au O'Melveny Conference Center à San Francisco, Californie.
Dave Rosa, président et CEO de NeuroOne, tiendra des réunions avec des investisseurs lors de cette conférence de deux jours, qui comprendra des tables rondes, des conférences principales et des présentations d'entreprises axées sur les dispositifs médicaux, les technologies d'imagerie, le diagnostic, l'IA/l'analyse de données et la santé numérique. La conférence MedInvest est reconnue comme une série d'événements majeure dans les secteurs de la santé et des sciences de la vie, organisant des événements semestriels dans les domaines de la biotechnologie, de la pharmacie, de la MedTech, de l'IA et de la santé numérique.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), ein Medizintechnologieunternehmen, das sich auf chirurgische Lösungen für neurologische Erkrankungen spezialisiert hat, hat seine Teilnahme an der bevorstehenden MedInvest MedTech, KI und Digital Health Konferenz bekannt gegeben. Die Veranstaltung findet am 3. und 4. Juni 2025 im O'Melveny Conference Center in San Francisco, Kalifornien, statt.
Dave Rosa, Präsident und CEO von NeuroOne, wird während dieser zweitägigen Konferenz Investorenmeetings durchführen. Die Konferenz umfasst Podiumsdiskussionen, Hauptvorträge und Unternehmenspräsentationen mit Schwerpunkt auf medizinischen Geräten, Bildgebungstechnologien, Diagnostik, KI/Datenanalyse und digitaler Gesundheit. Die MedInvest-Konferenz gilt als eine der führenden Veranstaltungsreihen im Bereich Gesundheitswesen und Lebenswissenschaften und richtet halbjährlich Events in den Bereichen Biotechnologie, Pharma, MedTech, KI und digitale Gesundheit aus.
- None.
- None.
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the MedInvest MedTech, AI and Digital Health Conference taking place in San Francisco, CA on June 3-4, 2025.
Dave Rosa, President and CEO of NeuroOne will be meeting with investors during the two-day event that will feature informative panel discussions, keynote talks and corporate presentations on medical devices, imaging technologies, diagnostics, AI/data analytics and digital health.
MedTech, AI & Digital Health Conference
Dates: June 3-4, 2025
Location: O’Melveny Conference Center, San Francisco, CA
Conference registration: https://www.medinvestconferences.com/register
The MedInvest Conference is a leading conference series in Healthcare and Life Sciences. MedInvest hosts semiannual conferences in Biotech and Pharma and in MedTech, AI, and Digital Health. To learn more or to register, please visit their website: https://www.medinvestconferences.com/
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
FAQ
When and where is NeuroOne (NMTC) presenting at the MedInvest Conference 2025?
Who will represent NeuroOne (NMTC) at the MedInvest Conference 2025?
What is the focus of NeuroOne Medical Technologies (NMTC)?
What topics will be covered at the 2025 MedInvest Conference?
